Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL98253 | 1.00 | CHRM3 (0.48) | CHRM3NAMPT | |
| SCHEMBL100315 | 0.93 | CHRM3 (0.51) | CHRM3 | |
| SCHEMBL100314 | 0.93 | CHRM3 (0.51) | CHRM3 | |
| SCHEMBL100473 | 0.86 | CHRM3 (0.51) | CHRM3 | |
| SCHEMBL15823264 | 0.86 | NDUFS8 (0.41) | NAMPT | |
| SCHEMBL15823262 | 0.86 | NDUFS8 (0.41) | NAMPT | |
| SCHEMBL15824492 | 0.84 | NAMPT (0.36) | CHRM3NAMPT | |
| SCHEMBL15824493 | 0.84 | NAMPT (0.36) | CHRM3NAMPT | |
| SCHEMBL15824490 | 0.84 | NAMPT (0.36) | CHRM3NAMPT | |
| SCHEMBL15824822 | 0.80 | NAMPT (0.41) | NAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9072734-B2 | Quaternary ammonium salt compounds | TEIJIN PHARMA LIMITED (JP) | 2015-07-07 | — | — | US | disclosed |
| EP-2426121-A1 | QUATERNARY AMMONIUM SALT COMPOUND | Teijin Pharma Limited (JP) | 2012-03-07 | — | — | EP | disclosed |
| US-20120046467-A1 | QUATERNARY AMMONIUM SALT COMPOUNDS | TEIJIN PHARMA LIMITED (JP) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046467-A1 | QUATERNARY AMMONIUM SALT COMPOUNDS | ADRB2, AGTR2, ADRB3 | CHRM3 9/4885NAMPT 4072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.